Modulation of bacterial quorum sensing with synthetic ligands
US-9796694-B2 · Oct 24, 2017 · US
US10322112B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10322112-B2 |
| Application number | US-201715431295-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 13, 2017 |
| Priority date | Feb 12, 2016 |
| Publication date | Jun 18, 2019 |
| Grant date | Jun 18, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods for modulating quorum sensing in certain Gram-negative bacteria having multiple QS systems including Las, Rhl, and Pqs with associated receptors (LasR, RhlR and PqsR) which are modulated by small molecule modulators, particularly non-native modulators. Certain combinations of modulators of Las, Rhl and Pqs exhibit improved inhibition of virulence in comparison to the respective individual modulators. In particular, certain combinations of modulators exhibit improved inhibition in nutritionally depleted environments. More specifically, certain combinations of modulators exhibit improved inhibition in environments depleted in phosphate and/or environments depleted in iron. Nutrient depleted environments can mimic environments associated with bacterial infection in humans and non-human animals. The methods are useful in particular for modulating QS in Pseudomonas and Burkholderia.
Opening claim text (preview).
We claim: 1. A method for inhibiting quorum sensing in a Gram-negative bacterium having multiple quorum sensing systems which comprises contacting the bacterium or an environment containing the bacterium with a combination of a first quorum sensing inhibitor selective for a first quorum sensing system and at least a second quorum sensing inhibitor selective for a second quorum sensing system, wherein the first quorum sensing inhibitor is: and the second quorum sensing inhibitor is: 2. The method of claim 1 , wherein the Gram-negative bacterium is a species of the genus Pseudomonas. 3. The method of claim 1 , wherein the first quorum-sensing inhibitor is: and the second quorum sensing inhibitor is: 4. The method of claim 1 , wherein, the environment of the Gram-negative bacterium is depleted in one or more nutrients needed for the bacterium. 5. The method of claim 4 , wherein the environment is depleted in iron or phosphate. 6. The method of claim 4 , wherein the Gram-negative bacterium is a strain of the genus Pseudomonas. 7. The method of claim 5 , wherein the Gram-negative bacterium is a strain of the genus Pseudomonas. 8. The method of claim 1 , wherein the Gram-negative bacterium is a strain of Pseudomonas aeruginosa. 9. The method of claim 4 , wherein the Gram-negative bacterium is a strain of Pseudomonas aeruginosa. 10. The method of claim 5 , wherein the Gram-negative bacterium is a strain of Pseudomonas aeruginosa.
having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide · CPC title
Lactones · CPC title
condensed with carbocyclic rings, e.g. benzimidazoles · CPC title
having five-membered rings · CPC title
having aromatic rings, e.g. colchicine, atenolol, progabide · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.